Impact of the COVID-19 pandemic on tuberculosis management in Spain

Other authors

Institut Català de la Salut

[Aznar ML, Sánchez-Montalvá A] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Mycobacteria Infection Study Group (GEIM, Spanish acronym) from Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, Spanish acronym), Spain. [Espinosa-Pereiro J, Saborit N, Molina I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Jové N, Sánchez Martinez F] Unitat Clínica de Tuberculosis, Hospital del Mar, Barcelona, Spain. [Pérez-Recio S] Tuberculosis Unit, Service of Infectious Diseases, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L’Hospitalet de Llobregat, Spain. [Jiménez-Fuentes MÁ, De Souza-Galvao ML] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Tórtola T] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Zules R] Servei de Medicina Preventiva i Epidemiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2021-12-07T13:21:27Z

2021-12-07T13:21:27Z

2021-07



Abstract

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Impacte; Tuberculosi


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Impacto; Tuberculosis


Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Impact; Tuberculosis


Background The impact of COVID-19 on the diagnosis and management of tuberculosis (TB) patients is unknown. Methods Participating centres completed a structured web-based survey regarding changes to TB patient management during the COVID-19 pandemic. The study also included data from participating centres on patients aged ≥18 diagnosed with TB in 2 periods: March 15 to June 30, 2020 and March 15 to June 30, 2019. Clinical variables and information about patient household contacts were retrospectively collected. Results A total of 7 (70%) TB units reported changes in their usual TB team operations. Across both periods of study, 169 patients were diagnosed with active TB (90 in 2019, 79 in 2020). Patients diagnosed in 2020 showed more frequent bilateral lesions in chest X-ray than patients diagnosed in 2019 ( P = 0.004). There was a higher percentage of latent TB infection and active TB among children in households of patients diagnosed in 2020, compared with 2019 ( P = 0.001). Conclusions The COVID-19 pandemic has caused substantial changes in TB care. TB patients diagnosed during the COVID-19 pandemic showed more extended pulmonary forms. The increase in latent TB infection and active TB in children of patient households could reflect increased household transmission due to anti-COVID-19 measures.


This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.


MLA was supported by a postdoctoral grant “Rio Hortega” and ASM was supported by a postdoctoral grant “Juan Rodés” (JE18/00022) from the Instituto de Salud Carlos III through the Spanish Ministry of economy and competitiveness.

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

International Journal of Infectious Diseases;108

https://doi.org/10.1016/j.ijid.2021.04.075

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)